The Present Status of Cardiac Surgery
The numerous reports appearing in current British, American and French journals testify to the interest aroused by recent advances in cardiac surgery. It may, therefore, be helpful to recall certain landmarks in its history and to review the present status of those procedures which have proved of value.
Congenital Heart Disease
Although the surgical treatment of pulmonary stenosis is now soundly established it is well to recall that until I944 these cases were of interest only to the morbid anatomist. Many types of congenital cardiac deformities had been described, but it was only when Helen Taussig realized that the essential abniormality in cyanotic children was a deficient blood flow from heart to lungs that therapeutic interest was aroused. With Taussig's support Blalock (I946) devised the operation of systemic-pulmonary anastomosis, since named after him. This increases pulmonary blood flow, alleviates the crippling disability and transforms the life of these pathetic children. This advance stimulated interest in the surgical treatment of heart disease and cardiologists began to assess the operability of an unsuspected backlog of thousands of similar cases.
Congenital deformities account for 2.5 per cent. of heart disease. The 
Constrictive Pericarditis
In constrictive pericarditis, pericardectomy to release the heart may produce marked improvement. There is an increasing tendency to operate early, under streptomycin cover, in young patients with a history of tuberculous pericarditis. In the older, chronic group the extent of the heart or liver damage influences the prognosis.
Mitral Stenosis
Undoubtedly the greatest advance in the surgery of the heart is the relief of the disabilities and poor prognosis of mitral stenosis. Surgical treatment of congenital deformities benefits those who are young;* the correction of mitral stenosis aids those in the prime of life who are of greater value to the community as mothers, bread-winners and artisans. It has been estimated that 25 per cent. of heart disease is of rheumatic origin and conservative estimates have indicated an incidence of 5,000 cases of mitral stenosis per million population. The problem today is not the selection of cases suitable for operation but the provision of adequate facilities to cope with the ever-growing waiting lists. The treatment of regurgitation is still in the experimental stage but both here and in America the insertion of a trans-ventricular pericardial flap below the mitral orifice has been successful.
The early results of mitral valvotomy have been dramatic in the majority of cases. Most patients are restored to an active life and enabled to recommence their previous employment. Provided active myocarditis does not recur there is no reason for believing these results to be temporary. The outlook in most cases has been radically altered.
Cardiac Trauma
Surgical treatment for cardiac trauma is seldom required in this country. However, experiences in two world wars and more recently in India have shown that wounds -of the heart are not invariably fatal. Elkin ('I94I) and Harkin (1946) reviewed the treatment of wounds and removal of foreign bodies and their success in these procedures has put this type of surgery on a firm basis. For those cases reaching hospital, transfusion and the relief of cardiac tamponnade by pericardial aspiration are indicated, but continued bleeding calls for exposure of the heart and suture of the wound.
Myocardial Ischaemia
In contrast to the successful treatment of deformities and mitral stenosis no great advance has been achieved in the alleviation of myocardial ischaemia by surgery. Despite a trial of many different procedures resection of the upper five thoracic sympathetic ganglia, if necessary on both sides, provides only symptomatic relief when active treatment is indicated.
The surgery of the heart is therefore in a phase of rapid development. Active experimental work and tentative clinical application are progressing and procedures for the treatment of aortic stenosis and regurgitation, atrial septal defect, pulmonary hypertension and aneurysms may soon be forthcoming. In 
